The Effect of Mandibular Advancement With Clear Aligners on Maxillary and Mandibular Volumes

NCT ID: NCT07056829

Last Updated: 2025-07-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

55 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-01

Study Completion Date

2025-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare the effectiveness of two different orthodontic treatment methods used in patients with skeletal Class II malocclusion, a condition in which the lower jaw is positioned backward. Approximately 80% of Class II malocclusions are due to mandibular retrusion. Therefore, functional appliances that stimulate mandibular growth in growing individuals have been widely used in orthodontics for many years.

In recent years, clear aligner systems have become increasingly popular in orthodontic practice. A mandibular advancement feature was recently integrated into these aligners, allowing for simultaneous tooth alignment and forward positioning of the lower jaw. In this study, the newly developed Mandibular Advancement Appliance (MAA), based on clear aligners, will be compared to the traditional functional appliance known as the Activator.

Who Can Participate in the Study? Children with retrusive lower jaws who are in the growth and development period Individuals with no prior orthodontic treatment Patients with specific levels of dental protrusion (overjet) Those with good general health and no contraindications for CBCT imaging What Will the Treatment Process Involve?

Participants will be randomly assigned to one of three groups:

MAA group (clear aligners with mandibular advancement) Activator group (traditional removable appliance) Control group (no treatment, only observation) The active treatment period will last approximately 7-8 months, followed by a retention phase. All patients will be monitored regularly, and strict adherence to appliance use will be expected.

How Will the Outcomes Be Assessed? Before and after the treatment period, participants will undergo cone-beam computed tomography (CBCT) scans to obtain detailed three-dimensional images of the jaws. These images will be analyzed to evaluate volumetric changes. All measurements will be performed by a trained orthodontic specialist using dedicated software.

Potential Benefits for Participants:

Participants will receive close clinical monitoring throughout the study period. The use of advanced imaging technologies may support the development of more effective and individualized treatment plans.

Safety and Confidentiality:

This study has received ethical approval and will be conducted in accordance with relevant data protection and research ethics standards. All personal data will be kept confidential. Written informed consent will be obtained from all participants and/or their legal guardians.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mandibular Retrognathia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This study follows a parallel assignment model. Participants are randomly assigned to one of three groups: the Mandibular Advancement Appliance (MAA) group, the Activator group, or the control group. Each group receives a different intervention or, in the case of the control group, no treatment, and all groups are observed over the same period without crossover between interventions.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MAA Group

Patients receive orthodontic treatment using clear aligners (Invisalign) with integrated mandibular advancement features (MAA). Advancement is performed in 2 mm increments every 8 weeks over \~8 months.

Group Type EXPERIMENTAL

Mandibular Advancement Appliance (Invisalign MA)

Intervention Type DEVICE

Clear aligner system with integrated buccal precision wings to posture the mandible forward.

Advancement protocol: 2 mm increments every 8 weeks. Total active treatment duration: \~8.15 months, followed by retention phase. Patients instructed to wear aligners ≥20 h/day, removing only for eating and oral hygiene.

Activator Group

Patients receive traditional removable functional appliance therapy (Activator) for \~7 months.

Group Type ACTIVE_COMPARATOR

Activator Appliance

Intervention Type DEVICE

Traditional removable functional appliance fabricated on a standardized bite registration.

Patients instructed to wear appliance 24 h/day except during meals and sports. Total active treatment duration: \~7.15 months, followed by retention phase.

Control Group

Patients receive no orthodontic treatment but are monitored for the same duration as the treatment groups.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mandibular Advancement Appliance (Invisalign MA)

Clear aligner system with integrated buccal precision wings to posture the mandible forward.

Advancement protocol: 2 mm increments every 8 weeks. Total active treatment duration: \~8.15 months, followed by retention phase. Patients instructed to wear aligners ≥20 h/day, removing only for eating and oral hygiene.

Intervention Type DEVICE

Activator Appliance

Traditional removable functional appliance fabricated on a standardized bite registration.

Patients instructed to wear appliance 24 h/day except during meals and sports. Total active treatment duration: \~7.15 months, followed by retention phase.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cervical vertebral maturation (CVM) stage 2 or 3
* Bilateral full or half cusp Class II molar relationship
* Skeletal Class II relationship associated with mandibular retrognathia (ANB angle \> 4° and SNB angle \< 78°)
* Horizontal or average growth pattern (SN-GoGn ≤ 38°)
* Overjet distance between +4 mm and +8 mm; (6) Good patient compliance throughout the treatment.

Exclusion Criteria

* CVM stage 5 or 6;(2) Previous orthodontic treatment;
* Presence of maxillary prognathism
* High-angle growth pattern (SN-GoGn \> 38°)
* Transverse orthodontic anomalies or facial asymmetry
* Palpation-induced tenderness or pain in the masticatory muscles
* Presence of clicking, crepitus, pain, or tenderness in the temporomandibular joint (TMJ)
* Congenital or acquired craniofacial deformities
* Poor patient compliance or oral hygiene
* Any condition that could interfere with CBCT imaging.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Batman University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nursezen Kavasoglu

Assistant Professor Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Batman University Faculty of Dentistry

Batman, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NK02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.